|
Ali, Ibraheem; Conrad, Ryan J; Verdin, Eric et al. (2018) Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics. Chem Rev 118:1216-1252
|
|
Gao, Yijun; Chang, Matthew T; McKay, Daniel et al. (2018) Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties. Cancer Discov 8:648-661
|
|
Dolor, Aaron; Szoka Jr, Francis C (2018) Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery. Mol Pharm 15:2069-2083
|
|
Bowman, C M; Benet, L Z (2018) An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation. Eur J Pharm Sci 123:502-514
|
|
Chan, Rosa; Benet, Leslie Z (2018) Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI. Toxicol Sci 162:499-508
|
|
Bisanz, Jordan E; Spanogiannopoulos, Peter; Pieper, Lindsey M et al. (2018) How to Determine the Role of the Microbiome in Drug Disposition. Drug Metab Dispos 46:1588-1595
|
|
Eclov, Rachel J; Kim, Mee J; Smith, Robin et al. (2018) Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity. Drug Metab Dispos 46:636-642
|
|
Chang, Matthew T; Penson, Alexander; Desai, Neil B et al. (2018) Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis. Clin Cancer Res 24:1965-1973
|
|
Li, M; Seiser, E L; Baldwin, R M et al. (2018) ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. Pharmacogenomics J 18:35-42
|
|
Rashkin, Sara R; Chua, Katherina C; Ho, Carol et al. (2018) A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance). Clin Pharmacol Ther :
|
Showing the most recent 10 out of 193 publications
